| Gilead Sciences, Inc. |
Level II |
6 | 6 |
$115,357 |
| Genentech, Inc. |
Level I |
4 | 13 |
$101,400 |
| Denali Therapeutics Inc. |
Level II |
3 | 3 |
$138,000 |
| Nautilus Subsidiary, Inc |
Level III |
3 | 3 |
$165,000 |
| Pacific Biosciences of California, Inc. |
Level III |
3 | 3 |
$162,046 |
| Amgen Inc. |
Level III |
2 | 2 |
$164,948 |
| Arcus Biosciences, Inc. |
Level II |
2 | 2 |
$133,725 |
| Astera Institute |
Level I |
2 | 2 |
$90,000 |
| CZ Biohub SF, LLC |
Level II |
2 | 2 |
$138,000 |
| Gilead Sciences, Inc. |
Level III |
2 | 2 |
$141,898 |
| Lawrence Berkeley National Laboratory |
Level II |
2 | 2 |
$104,416 |
| NTESS, LLC |
Level I |
2 | 2 |
$106,582 |
| Roche Molecular Systems, Inc. |
Level II |
2 | 2 |
$146,400 |
| Until Labs, Inc. |
Level II |
2 | 2 |
$115,357 |
| Vaxcyte, Inc. |
Level IV |
2 | 2 |
$183,009 |
| 10x Genomics, Inc. |
Level II |
1 | 1 |
$133,000 |
| 10x Genomics, Inc. |
Level III |
1 | 1 |
$142,000 |
| 10x Genomics, Inc. |
Level IV |
1 | 1 |
$178,000 |
| 92Bio, Inc. |
Level II |
1 | 1 |
$130,000 |
| ABBVIE INC. |
Level IV |
1 | 1 |
$200,000 |
| ACROCYTE THERAPEUTICS INC. |
Level II |
1 | 1 |
$115,357 |
| Addition Therapeutics, Inc. |
Level I |
1 | 1 |
$99,100 |
| Advanced Cell Diagnostics, Inc. |
Level II |
1 | 1 |
$115,357 |
| Alamar Biosciences, Inc. |
Level II |
1 | 1 |
$130,000 |
| Alkali Labs, Inc. |
Level II |
1 | 1 |
$155,000 |
| Amgen Inc. |
Level II |
1 | 1 |
$160,000 |
| Bio-Rad Laboratories, Inc. |
Level III |
1 | 1 |
$141,898 |
| Biogen, Inc. |
Level I |
1 | 1 |
$88,816 |
| BioMarin Pharmaceutical Inc. |
Level II |
1 | 1 |
$116,000 |
| BioMarin Pharmaceutical Inc. |
Level III |
1 | 1 |
$141,898 |
| Bionova Scientific LLC |
Level II |
1 | 1 |
$115,357 |
| Buck Institute for Research on Aging |
Level I |
1 | 1 |
$60,237 |
| Calico Life Sciences LLC |
Level II |
1 | 1 |
$160,000 |
| Calico Life Sciences LLC |
Level III |
1 | 1 |
$146,000 |
| Calico Life Sciences LLC |
Level IV |
1 | 1 |
$177,000 |
| CANVENTA LIFE SCIENCES, INC. |
Level II |
1 | 1 |
$125,040 |
| Carl Zeiss Microscopy, LLC |
Level IV |
1 | 1 |
$214,910 |
| Character Biosciences, Inc. |
Level II |
1 | 1 |
$115,357 |
| CZ Biohub SF, LLC |
Level I |
1 | 1 |
$120,000 |
| Elegen Corp |
Level IV |
1 | 1 |
$168,438 |
| Eli Lilly and Company |
Level II |
1 | 1 |
$146,970 |
| Eli Lilly and Company |
Level III |
1 | 1 |
$146,970 |
| Episteme, Inc. |
Level I |
1 | 1 |
$90,000 |
| The Fountain Group, LLC |
Level II |
1 | 1 |
$124,800 |
| Freenome Holdings, Inc. |
Level II |
1 | 1 |
$115,357 |
| Freenome Holdings, Inc. |
Level III |
1 | 1 |
$200,000 |
| Genentech, Inc. |
Level II |
1 | 1 |
$115,357 |
| Genentech, Inc. |
Level III |
1 | 1 |
$141,898 |
| Hexagon Bio, Inc. |
Level I |
1 | 1 |
$150,000 |
| Hexagon Bio, Inc. |
Level II |
1 | 1 |
$140,000 |
| Howard Hughes Medical Institute |
Level II |
1 | 1 |
$81,000 |
| Interdict Bio, Inc. |
Level III |
1 | 1 |
$142,000 |
| The J. David Gladstone Institutes |
Level III |
1 | 1 |
$75,505 |
| Lawrence Berkeley National Laboratory |
Level III |
1 | 1 |
$123,427 |
| Lawrence Livermore National Security, LLC |
Level II |
1 | 1 |
$185,612 |
| Leland Stanford Jr. Univ/SLAC National Accelerator Lab |
Level II |
1 | 1 |
$75,000 |
| Lume Health Technologies Inc. |
Level II |
1 | 1 |
$120,000 |
| MRL San Francisco, LLC |
Level II |
1 | 1 |
$159,600 |
| Nautilus Subsidiary, Inc |
Level II |
1 | 1 |
$115,400 |
| Northern California Institute for Research and Education |
Level II |
1 | 1 |
$70,304 |
| Novartis Institutes for BioMedical Research, Inc. |
Level II |
1 | 1 |
$115,357 |
| Novo Holdings (US) Inc. |
Level I |
1 | 1 |
$164,000 |
| Nurix Therapeutics, Inc. |
Level III |
1 | 1 |
$150,000 |
| Office of Environmental Health Hazard Assessment |
Level I |
1 | 1 |
$114,876 |
| ProMab Biotechnologies, Inc. |
Level I |
1 | 1 |
$90,000 |
| Qymune Inc |
Level I |
1 | 1 |
$100,000 |
| REVOLUTION MEDICINES, INC. |
Level II |
1 | 1 |
$165,550 |
| REVOLUTION MEDICINES, INC. |
Level III |
1 | 1 |
$168,000 |
| Ridge Biotechnologies, Inc. |
Level I |
1 | 1 |
$90,000 |
| Sana Biotechnology, Inc. |
Level IV |
1 | 1 |
$190,000 |
| Slingshot Biosciences, Inc. |
Level III |
1 | 1 |
$146,000 |
| Soleil Labs LLC |
Level III |
1 | 1 |
$141,898 |
| Twist Bioscience Corporation |
Level I |
1 | 1 |
$88,816 |
| University of California, San Francisco |
Level II |
1 | 1 |
$100,700 |
| University of California, San Francisco |
Level III |
1 | 1 |
$100,700 |
| Vaxcyte, Inc. |
Level II |
1 | 1 |
$125,000 |
| Vaxcyte, Inc. |
Level III |
1 | 1 |
$152,300 |
| Vir Biotechnology, Inc. |
Level I |
1 | 1 |
$108,159 |
| Vitalant |
Level III |
1 | 1 |
$82,450 |
| Vivid BioInnovations PBC |
Level IV |
1 | 1 |
$168,480 |
| Wild Type, Inc. |
Level II |
1 | 1 |
$135,000 |
| Xaira Therapeutics, Inc. |
Level IV |
1 | 1 |
$180,000 |
| Eversana Life Science Services LLC |
Level III |
1 | 1 |
$145,000 |
| Metagenomi, Inc. |
Level II |
1 | 1 |
$120,000 |
| Nurix Therapeutics, Inc. |
Level II |
1 | 1 |
$110,000 |
| Prothena Biosciences Inc. |
Level III |
1 | 1 |
$130,437 |
| University of California, San Francisco |
Level II |
1 | 1 |
$148,900 |
| University of California, San Francisco |
not stated |
79 | 79 |
$83,600 |
| University of California, Berkeley |
not stated |
7 | 7 |
$77,030 |
| Lawrence Berkeley National Laboratory |
not stated |
4 | 4 |
$80,796 |